KEYTRUDA® (pembrolizumab) Homepage for Patient Site
KEYTRUDA is a prescription medicine used to treat: a kind of lung cancer called non–small cell lung cancer (NSCLC).. It may be used in combination with chemotherapy that contains platinum and another chemotherapy medicine before surgery when you have early-stage NSCLC, which can be removed by surgery, and then continued alone after surgery to help prevent your lung cancer from coming back.
KEYTRUDA® (pembrolizumab) Homepage for Patient Site
KEYTRUDA is a medicine that may treat certain cancers by working with your immune system. KEYTRUDA can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become severe or life-threatening and can lead to death. You can have more than one of these ...
KEYTRUDA® (pembrolizumab) Homepage for Patient Site
KEYTRUDA is a medicine that may treat certain cancers by working with your immune system. KEYTRUDA can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become severe or life-threatening and can lead to death. You can have more than one of these ...
KEYTRUDA® (pembrolizumab) Homepage for Patient Site
1 Milliman, Inc., Expected Patient Out-of-Pocket Costs for Keytruda® (pembrolizumab), June 2024. Based on an analysis of 2021 and 2022 commercial and Medicare claims for 200 mg doses of KEYTRUDA. Commissioned by Merck Sharp & Dohme LLC a subsidiary of Merck & Co. Inc. Milliman’s analysis of a patient’s out-of-pocket payments for KEYTRUDA ...
KEYTRUDA® (pembrolizumab) Homepage for Patient Site
KEYTRUDA is a prescription medicine used to treat a kind of bladder cancer called urothelial cancer. KEYTRUDA may be used alone when your cancer has not spread to nearby tissue in the bladder, but is at high-risk for spreading (high-risk, non-muscle invasive bladder cancer [NMIBC]) and when your tumor is a type called “carcinoma in …
KEYTRUDA® (pembrolizumab) Homepage for Patient Site
KEYTRUDA. Understanding head and neck squamous cell cancer (HNSCC) “Head and neck cancer” is a term used to describe cancers in and around the head and neck, such as in the throat, lips, gums, or tongue. The specific type of head and neck cancer you have depends on what kinds of cells are affected and where the cancer actually started.
KEYTRUDA® (pembrolizumab) Homepage for Patient Site
Immunotherapy: Works with your own immune system to help detect and fight cancer.KEYTRUDA is an FDA-approved immunotherapy for advanced melanoma. Surgery: Removes cancer cells.; Radiation Therapy: Uses high-energy rays (like x-rays) to kill cancer cells.; Chemotherapy: Uses one or more drugs to kill cancer cells.; Targeted Therapy: Uses medicines that target and disrupt certain parts of the ...
Clinical Trial Results for Advanced Melanoma and the Adjuvant …
The quick start guide for KEYTRUDA takes you step-by-step through some information in preparation for your treatment, possible side effects, and more. Start now. Chat; Cancer Type; Sign Up for Support; Chat; Menu Melanoma RESULTS …